康华生物(300841.SZ)：前三季净利润1.89亿元 同比下降53.41%

Core Viewpoint - Kanghua Biotech reported a significant decline in both revenue and net profit for the first three quarters of the year, indicating potential challenges in its business performance [1] Financial Performance - The company's operating revenue for the first three quarters was 840 million yuan, representing a year-on-year decrease of 20.78% [1] - The net profit attributable to shareholders was 189 million yuan, down 53.41% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 183 million yuan, reflecting a year-on-year decline of 55.57% [1]